{"id":7305,"date":"2024-08-29T19:09:25","date_gmt":"2024-08-29T16:09:25","guid":{"rendered":"https:\/\/www.chemi-pharm.com\/?p=7305"},"modified":"2024-08-29T19:44:20","modified_gmt":"2024-08-29T16:44:20","slug":"kuberturvalisuse-taseme-kaardistamist-rahastab-eis","status":"publish","type":"post","link":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/","title":{"rendered":"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS"},"content":{"rendered":"\n<p>Aktsiaselts Chemi-Pharm kaardistab oma k\u00fcberturvalisuse taseme Ettev\u00f5tluse ja Innovatsiooni Sihtasutus (EIS) toetusprogrammi raames ajavahemikul 01.08.2024 kuni 02.09.2024.<\/p>\n\n\n\n<p>Arvestades praegust IT-julgeoleku olukorda ja k\u00fcberr\u00fcnnete arvu suurenemisest tulenevaid riske, on oluline saada valdkonna ekspertidelt p\u00f5hjalik ja terviklik \u00fclevaade ettev\u00f5tte k\u00fcberturvalisuse olukorrast. See aitab riske m\u00f5ista ja IT-s\u00fcsteemi turvalisust edasi arendada.<\/p>\n\n\n\n<p>Projekti eesm\u00e4rk on saada terviklik \u00fclevaade IT-s\u00fcsteemi k\u00fcberturvalisuse tasemest, mis on aluseks k\u00fcberturvalisuse edasisel arendamisel infos\u00fcsteemi ja ettev\u00f5tte kaitseks. Selle projekti tulemusena loodav ettev\u00f5tte k\u00fcberturvalisuse taseme teekaart on sisendiks Chemi-Pharmi k\u00fcberturvalisuse taseme t\u00f5stmiseks.<\/p>\n\n\n\n<p>Projekti kogumaksumus on 11 856 EUR, millest 50% on rahastatud Euroopa Liidu vahenditest.<\/p>\n\n\n\n<p>Projekti toetab Euroopa K\u00fcberkompetentsikeskus oma liikmetega.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"622\" height=\"329\" src=\"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png\" alt=\"\" class=\"wp-image-7306\" srcset=\"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png 622w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image-300x159.png 300w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image-600x317.png 600w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image-200x106.png 200w\" sizes=\"auto, (max-width: 622px) 100vw, 622px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"Aktsiaselts Chemi-Pharm kaardistab oma k\u00fcberturvalisuse taseme Ettev\u00f5tluse ja Innovatsiooni Sihtasutus (EIS) toetusprogrammi raames ajavahemikul 01.08.2024 kuni 02.09.2024. Arvestades praegust IT-julgeoleku olukorda ja k\u00fcberr\u00fcnnete arvu suurenemisest tulenevaid riske, on oluline saada valdkonna ekspertidelt p\u00f5hjalik ja terviklik \u00fclevaade ettev\u00f5tte k\u00fcberturvalisuse olukorrast. See aitab riske m\u00f5ista ja IT-s\u00fcsteemi turvalisust edasi arendada. Projekti eesm\u00e4rk on saada terviklik \u00fclevaade IT-s\u00fcsteemi [&hellip;]","protected":false},"author":13,"featured_media":7306,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","ngg_post_thumbnail":0,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-7305","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uudised-est"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>K\u00fcberturvalisuse taseme kaardistamist rahastab EIS - Chemi-Pharm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS - Chemi-Pharm\" \/>\n<meta property=\"og:description\" content=\"Aktsiaselts Chemi-Pharm kaardistab oma k\u00fcberturvalisuse taseme Ettev\u00f5tluse ja Innovatsiooni Sihtasutus (EIS) toetusprogrammi raames ajavahemikul 01.08.2024 kuni 02.09.2024. Arvestades praegust IT-julgeoleku olukorda ja k\u00fcberr\u00fcnnete arvu suurenemisest tulenevaid riske, on oluline saada valdkonna ekspertidelt p\u00f5hjalik ja terviklik \u00fclevaade ettev\u00f5tte k\u00fcberturvalisuse olukorrast. See aitab riske m\u00f5ista ja IT-s\u00fcsteemi turvalisust edasi arendada. Projekti eesm\u00e4rk on saada terviklik \u00fclevaade IT-s\u00fcsteemi [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemi-Pharm\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/chemipharmeesti\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-29T16:09:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-29T16:44:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png\" \/>\n\t<meta property=\"og:image:width\" content=\"622\" \/>\n\t<meta property=\"og:image:height\" content=\"329\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Justin Hein\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/\"},\"author\":{\"name\":\"Justin Hein\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/d50f99cf606bd8711aa1dee81c831e45\"},\"headline\":\"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS\",\"datePublished\":\"2024-08-29T16:09:25+00:00\",\"dateModified\":\"2024-08-29T16:44:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/\"},\"wordCount\":121,\"publisher\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/image.png\",\"articleSection\":[\"Uudised eestikeelsed\"],\"inLanguage\":\"et\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/\",\"name\":\"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS - Chemi-Pharm\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/image.png\",\"datePublished\":\"2024-08-29T16:09:25+00:00\",\"dateModified\":\"2024-08-29T16:44:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/image.png\",\"contentUrl\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/image.png\",\"width\":622,\"height\":329,\"caption\":\"ECCC, Kaasrahastanud Euroopa Liit\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#website\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/\",\"name\":\"Chemi-Pharm\",\"description\":\"Chemi-Pharm&#039;i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt\",\"publisher\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#organization\",\"name\":\"Chemi-Pharm\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"contentUrl\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"width\":282,\"height\":27,\"caption\":\"Chemi-Pharm\"},\"image\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/chemipharmeesti\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/d50f99cf606bd8711aa1dee81c831e45\",\"name\":\"Justin Hein\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g\",\"caption\":\"Justin Hein\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS - Chemi-Pharm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/","og_locale":"et_EE","og_type":"article","og_title":"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS - Chemi-Pharm","og_description":"Aktsiaselts Chemi-Pharm kaardistab oma k\u00fcberturvalisuse taseme Ettev\u00f5tluse ja Innovatsiooni Sihtasutus (EIS) toetusprogrammi raames ajavahemikul 01.08.2024 kuni 02.09.2024. Arvestades praegust IT-julgeoleku olukorda ja k\u00fcberr\u00fcnnete arvu suurenemisest tulenevaid riske, on oluline saada valdkonna ekspertidelt p\u00f5hjalik ja terviklik \u00fclevaade ettev\u00f5tte k\u00fcberturvalisuse olukorrast. See aitab riske m\u00f5ista ja IT-s\u00fcsteemi turvalisust edasi arendada. Projekti eesm\u00e4rk on saada terviklik \u00fclevaade IT-s\u00fcsteemi [&hellip;]","og_url":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/","og_site_name":"Chemi-Pharm","article_publisher":"https:\/\/www.facebook.com\/chemipharmeesti","article_published_time":"2024-08-29T16:09:25+00:00","article_modified_time":"2024-08-29T16:44:20+00:00","og_image":[{"width":622,"height":329,"url":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png","type":"image\/png"}],"author":"Justin Hein","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/#article","isPartOf":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/"},"author":{"name":"Justin Hein","@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/person\/d50f99cf606bd8711aa1dee81c831e45"},"headline":"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS","datePublished":"2024-08-29T16:09:25+00:00","dateModified":"2024-08-29T16:44:20+00:00","mainEntityOfPage":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/"},"wordCount":121,"publisher":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#organization"},"image":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/#primaryimage"},"thumbnailUrl":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png","articleSection":["Uudised eestikeelsed"],"inLanguage":"et"},{"@type":"WebPage","@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/","url":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/","name":"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS - Chemi-Pharm","isPartOf":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#website"},"primaryImageOfPage":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/#primaryimage"},"image":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/#primaryimage"},"thumbnailUrl":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png","datePublished":"2024-08-29T16:09:25+00:00","dateModified":"2024-08-29T16:44:20+00:00","breadcrumb":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/"]}]},{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/#primaryimage","url":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png","contentUrl":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png","width":622,"height":329,"caption":"ECCC, Kaasrahastanud Euroopa Liit"},{"@type":"BreadcrumbList","@id":"https:\/\/test2.chemi-pharm.com\/et\/kuberturvalisuse-taseme-kaardistamist-rahastab-eis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/test2.chemi-pharm.com\/et\/"},{"@type":"ListItem","position":2,"name":"K\u00fcberturvalisuse taseme kaardistamist rahastab EIS"}]},{"@type":"WebSite","@id":"https:\/\/test2.chemi-pharm.com\/et\/#website","url":"https:\/\/test2.chemi-pharm.com\/et\/","name":"Chemi-Pharm","description":"Chemi-Pharm&#039;i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt","publisher":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/test2.chemi-pharm.com\/et\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"},{"@type":"Organization","@id":"https:\/\/test2.chemi-pharm.com\/et\/#organization","name":"Chemi-Pharm","url":"https:\/\/test2.chemi-pharm.com\/et\/","logo":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/logo\/image\/","url":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","contentUrl":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","width":282,"height":27,"caption":"Chemi-Pharm"},"image":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/chemipharmeesti"]},{"@type":"Person","@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/person\/d50f99cf606bd8711aa1dee81c831e45","name":"Justin Hein","image":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/secure.gravatar.com\/avatar\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g","caption":"Justin Hein"}}]}},"author_meta":{"display_name":"Justin Hein","author_link":"https:\/\/test2.chemi-pharm.com\/et\/author\/justin\/"},"featured_img":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image-300x159.png","uagb_featured_image_src":{"full":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png",622,329,false],"thumbnail":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image-150x150.png",150,150,true],"medium":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image-300x159.png",300,159,true],"medium_large":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png",622,329,false],"large":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png",622,329,false],"1536x1536":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png",622,329,false],"2048x2048":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image.png",622,329,false],"news_thumb":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image-600x317.png",600,317,true],"custom_thumb":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2024\/08\/image-200x106.png",200,106,true]},"uagb_author_info":{"display_name":"Justin Hein","author_link":"https:\/\/test2.chemi-pharm.com\/et\/author\/justin\/"},"uagb_comment_info":0,"uagb_excerpt":"Aktsiaselts Chemi-Pharm kaardistab oma k\u00fcberturvalisuse taseme Ettev\u00f5tluse ja Innovatsiooni Sihtasutus (EIS) toetusprogrammi raames ajavahemikul 01.08.2024 kuni 02.09.2024. Arvestades praegust IT-julgeoleku olukorda ja k\u00fcberr\u00fcnnete arvu suurenemisest tulenevaid riske, on oluline saada valdkonna ekspertidelt p\u00f5hjalik ja terviklik \u00fclevaade ettev\u00f5tte k\u00fcberturvalisuse olukorrast. See aitab riske m\u00f5ista ja IT-s\u00fcsteemi turvalisust edasi arendada. Projekti eesm\u00e4rk on saada terviklik \u00fclevaade IT-s\u00fcsteemi&hellip;","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/test2.chemi-pharm.com\/et\/category\/uudised-est\/\" class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 2 aastat ago","modified":"Updated 2 aastat ago"},"absolute_dates":{"created":"Posted on 29. aug. 2024","modified":"Updated on 29. aug. 2024"},"absolute_dates_time":{"created":"Posted on 29. aug. 2024 07:09","modified":"Updated on 29. aug. 2024 07:44"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/7305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/comments?post=7305"}],"version-history":[{"count":2,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/7305\/revisions"}],"predecessor-version":[{"id":7310,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/7305\/revisions\/7310"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/media\/7306"}],"wp:attachment":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/media?parent=7305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/categories?post=7305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/tags?post=7305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}